What is the treatment for Pyelonephritis (infection of the kidney)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pyelonephritis treatment should involve antibiotics, with oral fluoroquinolones like ciprofloxacin (500mg twice daily for 5-7 days) or levofloxacin (750mg once daily for 5-7 days) being effective first-line options for uncomplicated cases, as recommended by the most recent guidelines 1.

Key Considerations

  • The choice of antibiotic should be based on the severity of the illness, local resistance patterns, and specific host factors, such as allergies.
  • Urine cultures and susceptibility testing should be performed to guide therapy, especially in areas with high rates of antibiotic resistance.
  • For more severe cases requiring hospitalization, intravenous options like ceftriaxone (1-2g daily) or a consolidated 24-h dose of an aminoglycoside can be used until clinical improvement, followed by oral therapy to complete 7-14 days total.

Treatment Options

  • Oral fluoroquinolones: ciprofloxacin (500mg twice daily for 5-7 days) or levofloxacin (750mg once daily for 5-7 days) are effective for uncomplicated cases.
  • Trimethoprim-sulfamethoxazole (160/800mg twice daily for 14 days) can be used if the pathogen is susceptible, but its use is limited due to high rates of resistance.
  • Intravenous options: ceftriaxone (1-2g daily), ampicillin plus gentamicin, or piperacillin-tazobactam until clinical improvement, followed by oral therapy to complete 7-14 days total.

Additional Recommendations

  • Patients should increase fluid intake, take analgesics like acetaminophen for pain and fever, and complete the full antibiotic course even if symptoms improve quickly.
  • Treatment success should be monitored through symptom resolution, typically within 48-72 hours.
  • Follow-up evaluation is recommended to ensure complete resolution of the infection, as supported by recent studies 1.

From the FDA Drug Label

Levofloxacin tablets are indicated for the treatment of acute pyelonephritis caused by Escherichia coli, including cases with concurrent bacteremia [see Clinical Studies (14.7,14.8)]. The treatment for Pyelonephritis (infection of the kidney) is levofloxacin.

  • The recommended treatment duration is 5 or 10 days.
  • Levofloxacin is effective against Escherichia coli, including cases with concurrent bacteremia 2.

From the Research

Treatment Overview

The treatment for Pyelonephritis (infection of the kidney) typically involves antibiotic therapy, with the choice of antibiotic and duration of treatment depending on the severity of the infection and the patient's overall health 3, 4, 5, 6, 7.

Antibiotic Options

  • Fluoroquinolones, such as ciprofloxacin and levofloxacin, are effective oral antibiotics for treating pyelonephritis 3, 4, 5, 6.
  • Extended-spectrum penicillins, amoxicillin-clavulanate potassium, cephalosporins, and trimethoprim-sulfamethoxazole are also effective alternatives 3, 5, 7.
  • Ceftriaxone has been shown to be more effective than levofloxacin in treating pyelonephritis, based on microbiological response 6.

Treatment Duration

  • The standard duration of therapy is 7 to 14 days 3, 4.
  • A 7-day course of ciprofloxacin has been shown to be effective in treating pyelonephritis in women, including older women and those with more severe infections 4.

Inpatient vs. Outpatient Treatment

  • Outpatient oral antibiotic therapy is suitable for patients with mild, uncomplicated pyelonephritis 3, 7.
  • Inpatient treatment is recommended for patients with complicated infections, sepsis, persistent vomiting, failed outpatient treatment, or extremes of age 3, 7.

Special Considerations

  • Pregnant patients with pyelonephritis are at increased risk of severe complications and should be admitted and treated initially with parenteral therapy 7.
  • Patients with urinary tract obstruction should be referred for urgent decompression 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.